Stockreport

Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights

Invivyd, Inc.  (IVVD) 
PDF Received emergency use authorization for PEMGARDA™, a monoclonal antibody (mAb) authorized in the U.S. for pre-exposure prophylaxis (PrEP) of COVID-19 in certain adults [Read more]